Wordt geladen...
Predictive biomarkers for tumor immune checkpoint blockade
The development of immune checkpoint inhibitors represented by PD-1 and PD-L1 has provided new hope for the treatment of advanced cancer patients. However, there are no effective predictive biomarkers, which have caused many limitations to the clinical application of immune checkpoint inhibitors. Th...
Bewaard in:
| Gepubliceerd in: | Cancer Manag Res |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6190817/ https://ncbi.nlm.nih.gov/pubmed/30349382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S179680 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|